ANR — Anatara Lifesciences Cashflow Statement
0.000.00%
Last trade - 00:00- AU$6.88m
- AU$5.80m
Annual cashflow statement for Anatara Lifesciences, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
C2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | 1.49 | 1.02 | 0.999 | 0.762 | 0.814 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -2.24 | -2.72 | -2.1 | -2.23 | -2.26 |
| Capital Expenditures | 0 | -0.004 | -0.004 | -0.007 | -0.002 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 2.15 | 4.05 | 0 | -0.05 | 0 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Cash from Investing Activities | 2.15 | 4.05 | -0.004 | -0.057 | -0.002 |
| Financing Cash Flow Items | — | — | -0.181 | -0.005 | -0.189 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | — | — | 2.85 | -0.022 | 1.49 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.088 | 1.32 | 0.75 | -2.31 | -0.769 |